We are live on ! Find out more
DRGS

RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS

Delisted

DRGS was delisted on the 6th of July, 2015.

Back to rankings

1 hedge funds and large institutions have $6K invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

50% less capital invested

Capital invested by funds: $12K → $6K (-$6K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$5.83K

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$10K
2
U
UBS
Switzerland
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
1
Citigroup
New York
$6K +$5.83K +125 New
Ameriprise
2
Ameriprise
Minnesota
– -$10K -221 Closed
U
3
UBS
Switzerland
– -$2K -41 Closed

DRGS Hedge Fund Activity: Q2 2014 in Review

1 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q2 2014, worth a combined $6K — down 50% from $12K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of DRGS and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Citigroup, opening a new position worth an estimated $5.83K. The largest seller was Ameriprise, exiting entirely with an estimated $10K sold.

  • 1 institutional investor held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q2 2014, down from 2 in Q1 2014.
  • Funds reported $6K of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q2 2014, down 50% quarter-over-quarter.
  • 1 fund opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q2 2014 and 2 closed out, a net change of -1 holder.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS buyer in Q2 2014 was Citigroup, an estimated $5.83K added.
  • The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS seller in Q2 2014 was Ameriprise, an estimated $10K sold.

Based on aggregated 13F filings for Q2 2014.